A Study of Docetaxel for Injection (Albumin Bound) in Patients With Advanced Pancreatic Cancer
Clinical trial NCT06492941 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT06492941
- Sponsor
- CSPC ZhongQi Pharmaceutical Technology Co., Ltd.
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2024-08-12
- Primary completion
- 2026-04-14
- Enrollment
- 142
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.